Growth Metrics

Omeros (OMER) Share-based Compensation Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 206.26%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -69.95%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 0.18%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.66%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 23.70%
10 Omeros 772.03 Mn 636.71 Mn 9.31 Mn 82.34%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 82.34%
Dec 31, 2025 -28.57%
Sep 30, 2025 -67.59%
Jun 30, 2025 -32.31%
Mar 31, 2025 -61.02%
Dec 31, 2024 -9.85%
Sep 30, 2024 -18.36%
Jun 30, 2024 -38.69%
Mar 31, 2024 -9.99%
Dec 31, 2023 -17.56%
Sep 30, 2023 -15.84%
Jun 30, 2023 -9.80%
Mar 31, 2023 -24.13%
Dec 31, 2022 -41.17%
Sep 30, 2022 -32.49%
Jun 30, 2022 -1.44%
Mar 31, 2022 18.99%
Dec 31, 2021 45.88%
Sep 30, 2021 48.90%
Jun 30, 2021 -18.45%
Mar 31, 2021 -5.90%
Dec 31, 2020 14.65%
Sep 30, 2020 9.38%
Jun 30, 2020 6.23%
Mar 31, 2020 3.02%
Dec 31, 2019 17.75%
Sep 30, 2019 19.36%
Jun 30, 2019 19.93%
Mar 31, 2019 13.76%
Dec 31, 2018 -13.03%
Sep 30, 2018 -3.68%
Jun 30, 2018 -4.21%
Mar 31, 2018 -9.46%
Dec 31, 2017 -19.35%
Sep 30, 2017 19.96%
Jun 30, 2017 20.00%
Mar 31, 2017 -25.92%
Dec 31, 2016 74.00%
Sep 30, 2016 6.69%
Jun 30, 2016 9.66%
Mar 31, 2016 75.69%
Dec 31, 2015 -39.82%
Sep 30, 2015 42.70%
Jun 30, 2015 46.01%
Mar 31, 2015 40.77%
Dec 31, 2014 103.13%
Sep 30, 2014 -24.69%
Jun 30, 2014 53.77%
Mar 31, 2014 63.59%
Dec 31, 2013 -5.84%
Sep 30, 2013 283.85%
Jun 30, 2013 86.29%
Mar 31, 2013 -3.36%
Dec 31, 2012 340.66%
Sep 30, 2012 23.34%
Jun 30, 2012 4.02%
Mar 31, 2012 146.94%
Dec 31, 2011 -24.67%
Sep 30, 2011 -18.64%